Background:The effect of elevated progesterone level on human chorionic gonadotropin (HCG) day in
in vitro fertilization cycles is controversial. Some suppose that rise in progesterone
level seems to have a negative impact on implantation and pregnancy by desynchronizing
the endometrium, while others disagree.Objective:To evaluate the superiority of the frozen cycle over fresh cycle on live birth in
patients with elevated progesterone level on HCG day.Materials and Methods:In this double-blind, randomized clinical trial, 72 women undergoing assisted
reproductive technology with elevated progesterone level (≥1.8 ng/dl) on HCG day were
included. The participants were grouped by fresh versus frozen embryo transfer,
randomly. Finally, the clinical pregnancy and live birth rate were compared.Results:The implantation rate was 21.51%. The clinical pregnancy rate was 47.22% in fresh
embryo transfer group (17/36) and 41.66% in frozen group (15/36) (p=0. 40). The live
birth rate was not significantly difference between two groups (p=0.56).Conclusion:None of the fresh and frozen cycles are superior to the other and we recommend
individualizing the decision for each patient. The frozen cycle may impose more
emotional stress on patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.